期刊文献+

色素上皮衍生因子在银屑病中的表达及意义

下载PDF
导出
摘要 目的:检测色素上皮衍生因子(PEDF)在银屑病中的表达。方法:采用免疫组化和RTPCR法检测20例银屑病皮损及20例正常皮肤组织中PEDF蛋白和mRNA的表达。结果:银屑病皮损中PEDF蛋白和mRNA的表达水平明显高于对照组,差异有统计学意义。结论:银屑病皮损中PEDF蛋白和mRNA的表达水平上调,可能参与银屑病的发病过程。
出处 《中国麻风皮肤病杂志》 2013年第5期321-324,共4页 China Journal of Leprosy and Skin Diseases
  • 相关文献

参考文献15

  • 1张学军.皮肤性病学.第7版.北京:人民卫生出版社,2011.141.
  • 2Becerra SP. Focus on Molecules: Pigment epithelium - derived fac-tor (PKDF) . Kxp Eye Kes, 2006,82(5): 739 - 740.
  • 3Nakajirna H,Nakajima K,Tarutani M,et al. The role of pigmentepithelium - derived factor as an adipokine in psoriasis. Arch Der-matol Res,2012,304(I):81 -84.
  • 4盛霞,黄国良.色素上皮衍生因子在糖尿病血管并发症中的潜在治疗作用[J].医学研究杂志,2012,41(8):184-186. 被引量:2
  • 5刘建猛,崔保霞,尹婷,张爱荣.色素上皮衍生因子在宫颈鳞癌中的表达及其意义[J].山东大学学报(医学版),2012,50(5):103-106. 被引量:1
  • 6Jang TJ,Kim SW, Lee KS. The expression of pigment epithelium -derived factor in bladder transitional cell carcinoma. Korean Journalof Pathology,2012,46(3) :261.
  • 7Stellmach V,Crawford SE,Zhou W, et al. Prevention of ischemia—induced retinopathy by the natural ocular antiangiogenic agentpigment epithelium - derived factor. Pnx: Natl Acad Sci, 2001, 98(5):2593-2597.
  • 8Hutchings H, Maitre BM, Toml>ran TJ, et al. Pigment epithelium-derived factor exerts opposite effects on endothelial cells of differ-ent phenotypes. Biochemical and Biophysical Research Communica-tions ,2002,294(4 ):764 - 769.
  • 9Ren JG, Jie C,Talbot C. How PEDF prevents angiogenesis: a hy-pothesized pathway, Med Hypotheses,2005,64( 1) : 74 - 78.
  • 10Abe R,Yamaqishi S, Fujita Y,et al. Topical application of anti-angiogenic peptides based on pigment epithelium - derived factorcan improve psoriasis. J Dermatol Sci,2010,57(3) : 183 - 191.

二级参考文献71

  • 1Detmar M, Velasco P, Richard L, et al. Expression of vascular en dothelial growth factor induces an invasive phenotype in human squamous cell carcinomas. Am J Pathol, 2000, 156: 159-167.
  • 2Hawighorst T, Velasco P, Streit M, et al. Thrombospondin-2 plays aprotective role in multistep carcinogenesis: a novel host anti-tumor defense mechanism. EMBO J, 2001, 20: 2631-2640.
  • 3Strieth S, Hartschuh W, Pilz L, et al. Angiogenic switch occurs late in squamous cell carcinomas of human skin. Br J Cancer, 2000, 82:591-600.
  • 4Bhushan M, Young HS, Brenchley PE, et al. Recent advances in cutaneous angiogenesis. Br J Dermatol, 2002, 147: 418-425.
  • 5Brown LF, Dezube BJ, Tognazzi K, et al. Expression of Tie1, Tie2,and angiopoietins 1, 2, and 4 in Kaposi's sarcoma and cutaneous angiosarcoma. Am J Pathol, 2000, 156: 2179-2183.
  • 6Velasco P, Lange-Asschenfeldt B. Dermatological aspects of angiogenesis. Br J Dermatol, 2002, 147: 841-852.
  • 7Albini A, Marchisone C, Del Grosso F, et al. Inhibition of angio genesis and vascular tumor growth by interferon-producing cells: A gene therapy approach. Am J Pathol, 2000, 156: 1381-1393.
  • 8Hem S, Allen MH, Sousa AR, et al. Immunohistochemical evalua tion of psoriatic plaques following selective photothermolysis of the superficial capillaries. Br J Dermatol, 2001, 145: 45-53.
  • 9Smyth AP, Rook SL, Detmar M, et al. Antisense oligonucleotides inhibit vascular endothelial growth factor/vascular permeability factor expression in normal human epidermal keratinocytes. J Invest Dermatol, 1997, 108: 523-526.
  • 10Longo R, Sarmiento R, Fanelli M, et al. Anti-angiogenic therapy: ratio nale, challenges and clinical studies. Angiogenesis., 2002, 5: 237.

共引文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部